Zobrazeno 1 - 10
of 18
pro vyhledávání: '"NATALIE S. HADDAD"'
Autor:
Matthew C. Woodruff, Kevin S. Bonham, Fabliha A. Anam, Tiffany A. Walker, Caterina E. Faliti, Yusho Ishii, Candice Y. Kaminski, Martin C. Ruunstrom, Kelly Rose Cooper, Alexander D. Truong, Adviteeya N. Dixit, Jenny E. Han, Richard P. Ramonell, Natalie S. Haddad, Mark E. Rudolph, Srilakshmi Yalavarthi, Viktoria Betin, Ted Natoli, Sherwin Navaz, Scott A. Jenks, Yu Zuo, Jason S. Knight, Arezou Khosroshahi, F. Eun-Hyung Lee, Ignacio Sanz
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract While immunologic correlates of COVID-19 have been widely reported, their associations with post-acute sequelae of COVID-19 (PASC) remain less clear. Due to the wide array of PASC presentations, understanding if specific disease features ass
Externí odkaz:
https://doaj.org/article/9d2aa0b3afa9462d9b276355450d5845
Autor:
Amy B. Karger, James D. Brien, Jayne M. Christen, Santosh Dhakal, Troy J. Kemp, Sabra L. Klein, Ligia A. Pinto, Lakshmanane Premkumar, John D. Roback, Raquel A. Binder, Karl W. Boehme, Suresh Boppana, Carlos Cordon-Cardo, James M. Crawford, John L. Daiss, Alan P. Dupuis, Ana M. Espino, Adolfo Firpo-Betancourt, Catherine Forconi, J. Craig Forrest, Roxie C. Girardin, Douglas A. Granger, Steve W. Granger, Natalie S. Haddad, Christopher D. Heaney, Danielle T. Hunt, Joshua L. Kennedy, Christopher L. King, Florian Krammer, Kate Kruczynski, Joshua LaBaer, F. Eun-Hyung Lee, William T. Lee, Shan-Lu Liu, Gerard Lozanski, Todd Lucas, Damodara Rao Mendu, Ann M. Moormann, Vel Murugan, Nkemakonam C. Okoye, Petraleigh Pantoja, Anne F. Payne, Jin Park, Swetha Pinninti, Amelia K. Pinto, Nora Pisanic, Ji Qiu, Carlos A. Sariol, Viviana Simon, Lusheng Song, Tara L. Steffen, E. Taylor Stone, Linda M. Styer, Mehul S. Suthar, Stefani N. Thomas, Bharat Thyagarajan, Ania Wajnberg, Jennifer L. Yates, Kimia Sobhani
Publikováno v:
mSphere, Vol 7, Iss 4 (2022)
ABSTRACT In October 2020, the National Cancer Institute (NCI) Serological Sciences Network (SeroNet) was established to study the immune response to COVID-19, and “to develop, validate, improve, and implement serological testing and associated tech
Externí odkaz:
https://doaj.org/article/15b0a867b0c944c198dfb5ce4d592d6a
Autor:
Matthew C. Woodruff, Richard P. Ramonell, Natalie S. Haddad, Fabliha A. Anam, Mark E. Rudolph, Tiffany A. Walker, Alexander D. Truong, Adviteeya N. Dixit, Jenny E. Han, Monica Cabrera-Mora, Martin C. Runnstrom, Regina Bugrovsky, Jennifer Hom, Erin C. Connolly, Igor Albizua, Vidhi Javia, Kevin S. Cashman, Doan C. Nguyen, Shuya Kyu, Ankur Singh Saini, Michael Piazza, Christopher M. Tipton, Arezou Khosroshahi, Greg Gibson, Greg S. Martin, Cheryl L. Maier, Annette Esper, Scott A. Jenks, F. Eun-Hyung Lee, Ignacio Sanz
Publikováno v:
medRxiv
Severe SARS-CoV-2 infection1 has been associated with highly inflammatory immune activation since the earliest days of the COVID-19 pandemic2–5. More recently, these responses have been associated with the emergence of self-reactive antibodies with
Autor:
Lin Wang, Marcelo Fernandez-Vina, E. Steve Woodle, F. Eun-Hyung Lee, Natalie S. Haddad, Madhav C. Menon, Alin Girnita, Patrick Ahearn, Andrea Morrison-Porter, Aditya Jain, Howard M. Gebel, Ignacio Sanz, Tanuja Yalamarti, Susan Hartzell, Jonathan S. Maltzman, Yorg Azzi, Enver Akalin, Paolo Cravedi, Marzuq Billah
Publikováno v:
J Am Soc Nephrol
BACKGROUND: Kidney transplant recipients are at increased risk of severe outcomes during COVID-19. Antibodies against the virus are thought to offer protection, but a thorough characterization of anti–SARS-CoV-2 immune globulin isotypes in kidney t
Autor:
Natalie S. Haddad, Doan C. Nguyen, Merin E. Kuruvilla, Andrea Morrison-Porter, Fabliha Anam, Kevin S. Cashman, Richard P. Ramonell, Shuya Kyu, Ankur Singh Saini, Monica Cabrera-Mora, Andrew Derrico, David Alter, John D. Roback, Michael Horwath, James B. O’Keefe, Henry M. Wu, An-Kwok Ian Wong, Alexandra W. Dretler, Ria Gripaldo, Andrea N. Lane, Hao Wu, Helen Y. Chu, Saeyun Lee, Mindy Hernandez, Vanessa Engineer, John Varghese, Rahul Patel, Anum Jalal, Victoria French, Ilya Guysenov, Christopher E. Lane, Tesfaye Mengistsu, Katherine Elizabeth Normile, Onike Mnzava, Sang Le, Ignacio Sanz, John L. Daiss, F. Eun-Hyung Lee
Publikováno v:
ImmunoHorizons. 5:322-335
SARS-CoV-2 has caused over 100,000,000 cases and almost 2,500,000 deaths globally. Comprehensive assessment of the multifaceted antiviral Ab response is critical for diagnosis, differentiation of severity, and characterization of long-term immunity,
Autor:
MARTIN C RUNNSTROM, NARAYANAIAH CHEEDARLA, PEDRO A LAMOTHE, SUNEETHAMMA CHEEDARLA, MAYURAN RAVINDRAN, RICHARD P RAMONELL, FABLIHA A ANAM, ROBERT SWERLICK, COLIN E SWENSON, CARMEN C POLITO, WENDY A NEVEU, RAHULKUMAR PATEL, CAROLINE Y KIM, IAN HENTENAAR, NATALIE S. HADDAD, JOHN DAISS, IGNACIO SANZ, SUNITA SHARMA, FERNANDO HOLGUIN, ANDREW NEISH, JOHN ROBACK, FRANCES E LEE
Publikováno v:
Chest. 162:A2652-A2653
Autor:
Natalie S. Haddad, Sophia Nozick, Geena Kim, Shant Ohanian, Colleen S. Kraft, Paulina A. Rebolledo, Yun Wang, Hao Wu, Adam Bressler, Sang Nguyet Thi Le, Merin Kuruvilla, Martin C. Runnstrom, Richard P. Ramonell, L. Edward Cannon, F. Eun-Hyung Lee, John L. Daiss
Publikováno v:
J Clin Microbiol
Within 8 weeks of primary Clostridioides difficile infection (CDI), as many as 30% of patients develop recurrent disease with the associated risks of multiple relapses, morbidity, and economic burden. There are no clear clinical correlates or validat
Autor:
Martin C. Runnstrom, Andrea Morrison-Porter, Mayuran Ravindran, Hannah Quehl, Richard P. Ramonell, Matthew Woodruff, Rahulkumar Patel, Caroline Kim, Natalie S. Haddad, F. Eun-Hyung Lee
Publikováno v:
American journal of respiratory and critical care medicine. 205(10)
Autor:
F. Eun-Hyung Lee, Natalie S. Haddad, John L. Daiss, Hao Wu, Sang Nguyet Thi Le, Adam Bressler, L. Edward Cannon, Shant Ohanian, Sophia Nozick, Colleen S. Kraft, Geena Kim, Yun F. Wang, Merin Kuruvilla, Paulina A. Rebolledo
BackgroundWithin eight weeks of primary Clostridioides difficile infection (CDI), as many as 30% of patients develop recurrent disease with the associated risks of multiple relapses, morbidity, and economic burden. There are no validated biomarkers p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a99156b66ae38cda9bc43354c22e2c8e
https://doi.org/10.1101/2021.11.04.21265901
https://doi.org/10.1101/2021.11.04.21265901
Autor:
Astrid Kosters, Brian S. Dobosh, Kathryn Musall, Devon J. Eddins, Frances Eun-Hyung Lee, Joshua D. Chandler, Natalie S. Haddad, Keivan Zandi, Raymond F. Schinazi, Eliver Ghosn, Junkai Yang, Richard P. Ramonell, Mindy R. Hernandez, Rabindra Tirouvanziam, Leda Bassit
SummaryIn late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China spurring the Coronavirus Disease-19 (COVID-19) pandemic that has resulted in over 219 million confirmed cases and nearly 4.6 million deaths wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea0c7262a18c485381a175b95944fa55
https://doi.org/10.1101/2021.10.22.465481
https://doi.org/10.1101/2021.10.22.465481